Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
Kahn Brothers Group Portfolio 13F
Kahn Brothers Group Holdings Activity
- Portfolio value:
- $552.09M≈ (+$36M≈)
- Previous value:
- $516.56M≈
- # of changes:
- 29
- New positions:
- 0
- Reported for:
- 30 Sep 2016 (Q3)
- Latest filing date:
- 01 Nov 2016
Kahn Brothers Group has disclosed a total of 29 changes to the portfolio in the (2016 Q3) SEC report(s): increased the number of shares of 4, decreased the number of shares of 23 and completely sold out 2 position(s).
What stocks did Kahn Brothers Group buy in 2016 Q3?
In the 2016 Q3 report(s) the following changes have been made to the top investments: (MRK) Merck & Company Inc (reduced shares -0.72%), (C) Citigroup Inc (added shares +1.30%), (HOLX) Hologic Inc (reduced shares -3.33%), (BP) BP PLC-SPONS ADR (added shares +4.01%) and (NYT) New York Times Company (reduced shares -0.57%).
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.